349 related articles for article (PubMed ID: 15806713)
1. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
[TBL] [Abstract][Full Text] [Related]
2. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
3. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
4. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.
Castaño G; Arruzazabala ML; Fernández L; Mas R; Carbajal D; Molina V; Illnait J; Mendoza S; Gámez R; Mesa M; Fernández J
Curr Ther Res Clin Exp; 2006 May; 67(3):174-92. PubMed ID: 24678094
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
[TBL] [Abstract][Full Text] [Related]
6. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
7. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Castaño G; Más R; Gámez R; Fernández L; Illnait J
Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits.
Gámez R; Mendoza S; Mas R; Noa M; Arruzazabala L; Carbajal D; Castaño G; Goicochea E; Mesa M; Mendoza N
Drugs R D; 2003; 4(4):219-29. PubMed ID: 12848586
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.
Arruzazabala ML; Molina V; Mas R; Fernández L; Carbajal D; Valdés S; Castaño G
Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):891-7. PubMed ID: 12207568
[TBL] [Abstract][Full Text] [Related]
11. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
12. Effects of D-003, a mixture of very long chain fatty acids purified from sugar cane wax, at 5 and 10 mg/day on platelet aggregation in healthy volunteers.
Arruzazabala ML; Molina V; Carbajal D; Fernández L; Mas R; Castaño G; Illnait J; Mendoza S; Fernańdez J
Int J Clin Pharmacol Res; 2005; 25(1):29-39. PubMed ID: 15868655
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-lowering effects of policosanol in rabbits.
Arruzazabala ML; Carbajal D; Mas R; Molina V; Valdes S; Laguna A
Biol Res; 1994; 27(3-4):205-8. PubMed ID: 8728832
[TBL] [Abstract][Full Text] [Related]
15. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
16. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
17. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
18. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers.
Carbajal D; Arruzazabala ML; Valdés S; Más R
Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):61-4. PubMed ID: 9482167
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Clubb FJ; Schmitz JM; Butler MM; Buja LM; Willerson JT; Campbell WB
Arteriosclerosis; 1989; 9(4):529-37. PubMed ID: 2751481
[TBL] [Abstract][Full Text] [Related]
20. [Effect of xiongshao capsule on lipid metabolism and platelet aggregation in experimental atherosclerosis rabbits].
Li LZ; Liu JG; Ma LB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1100-3. PubMed ID: 19317167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
